Expert NetworkExpert InterviewSGMT

Slingshot members are talking to an expert! The topic is:

Discussing the potential of Sagimet's denifanstat in Biopsy-Confirmed F2/F3 NASH with a focus on the Phase 2b FASCINATE-2 trial

Executed on:Feb 6, 2024 3:00 PM EDT
Call Duration:30 minutes

Expert Profile

ExpertBlinded Expert
Institution: Texas Liver Institute
  • Medical Director and VP of Research and Development at the Texas Liver Institute and Professor of Medicine at the University of Texas Health San Antonio.
  • Manages hundreds of patients with NASH.
  • Has authored over 400 peer-reviewed publications in medical journals.

Interview Goal

This interview will focus on Sagimet's Topline Results from Phase 2b FASCINATE-2 Clinical Trial of Denifanstat in Biopsy-Confirmed F2/F3 NASH

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.